Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Linagliptin”

160 trials

Showing 20 of 160 results

Post-approval studies (Phase 4)Study completedNCT02442817
What this trial is testing

Linagliptin and Mesenchymal Stem Cells: A Pilot Study

Who this might be right for
Schizophrenia
University of Nevada, Reno 10
Early research (Phase 1)Study completedNCT02183441
What this trial is testing

Bioavailability of BI 1356 After Co-administration With Ritonavir Compared to the Bioavailability of BI 1356 Alone in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 12
Early research (Phase 1)Study completedNCT02183623
What this trial is testing

The Effect of Multiple Oral Doses of BI 1356 BS on Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of Simvastatin and on the Pharmacokinetics of Its Metabolite Simvastatin Acid in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 20
Early research (Phase 1)Study completedNCT02175394
What this trial is testing

Effect of Multiple BI 1356 Doses of on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Female Premenopausal Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 18
Post-approval studies (Phase 4)UnknownNCT05200793
What this trial is testing

Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome (PCOS)
Alexandria University 75
Not applicableEnded earlyNCT04180813
What this trial is testing

Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 85
Large-scale testing (Phase 3)Study completedNCT01087502
What this trial is testing

Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 241
Large-scale testing (Phase 3)Study completedNCT00622284
What this trial is testing

Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,560
Early research (Phase 1)Study completedNCT01540487
What this trial is testing

Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /Metformin

Who this might be right for
Healthy
Boehringer Ingelheim 48
Not applicableStudy completedNCT04735042
What this trial is testing

SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections.

Who this might be right for
Type 2 DiabetesUrinary Tract Infections
University of Pisa 60
Testing effectiveness (Phase 2)Study completedNCT00716092
What this trial is testing

The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 121
Early research (Phase 1)Study completedNCT02173665
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS Administered to Healthy Male Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 64
Early research (Phase 1)Study completedNCT05874167
What this trial is testing

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers

Who this might be right for
Healthy Subjects
Dong Wha Pharmaceutical Co. Ltd. 50
Not applicableStudy completedNCT05130463
What this trial is testing

Esgliteo Post Marketing Surveillance (PMS) in Korean Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,053
Early research (Phase 1)Study completedNCT02183402
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Digoxin With or Without Co-administration of BI 1356 in Healthy Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 20
Post-approval studies (Phase 4)Study completedNCT02004366
What this trial is testing

Linagliptin Inpatient Trial

Who this might be right for
Type 2 Diabetes
Emory University 295
Post-approval studies (Phase 4)Study completedNCT01903070
What this trial is testing

Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment

Who this might be right for
Diabetes Mellitus
Profil Institut für Stoffwechselforschung GmbH 99
Large-scale testing (Phase 3)Study completedNCT01734785
What this trial is testing

Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 607
Post-approval studies (Phase 4)UnknownNCT02429232
What this trial is testing

A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers

Who this might be right for
OsteoporosisDiabetes Mellitus
National Taiwan University Hospital 160
Early research (Phase 1)Study completedNCT02183584
What this trial is testing

Study to Evaluate the Effect of Multiple Doses of Rifampicin on the Multiple-dose Pharmacokinetics of Linagliptin in Healthy Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 16
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation